Europe Custom Antibody Market is expected to reach US$ 213.7 Mn by 2028

Antibody Development Segment has the Largest Share of Service in the Europe Custom Antibody Market during 2021–2028

According to The Insight Partners market research study on “Europe Custom Antibody Market to 2028 – COVID-19 Impact and Regional Analysis and Forecast by Service, Type, Source, Research Area, and End User,” is expected to reach US$ 213.7 million by 2028 from US$ 102.5 million in 2021. The market is estimated to grow at a CAGR of 11.1% from 2021 to 2028. The report provides trends prevailing in the Europe custom antibody market along with the drivers and restraints pertaining to the market growth. The growth of this market is estimated to grow owing to key driving factors such as the high demand in research, market consolidations strategies adopted by biotechnology companies, and production and development services offered by custom antibody providers are the key factors driving the market growth. However, the market is expected experiencing slow growth during the forecast period owing to the high cost of production.

Countries in the European regions were profoundly affected due to the COVID-19 pandemic. For instance, countries such as Italy, Spain, and France have reported the highest number of positive cases and have registered the maximum number of deaths. Several companies have experienced severe losses in the last quarter of 2019; they have also negatively influenced the first and second quarters of 2020. Hence, the impact of COVID 19 on the European market was immediate and drastic. The custom antibody supply chain, which is already logistically complicated, has to face new challenges. The custom antibody market has also witnessed some shortfall at the beginning of the COVID 19 crisis due to disruption in supply chain and demand due to lockdown announced by most European countries. This result may last till the end of 2020 as most of the market players in Europe yet to adopt the novel diagnostic tests for COVID 19. However, in the extended period, the requirement for custom antibodies is expected to increase due to supportive government initiatives. For instance, in May 2020, ProteoGenix launched the first Human Immune COVID-19 library for the fast development of potent antibodies against SARS-CoV-2. Hence, the European custom antibody market will likely show significant growth prospects during this pandemic and forecasted year. Therefore, the preference for adopting custom antibody provides a favorable environment for the growth of the Europe custom antibody market during the forecast period.

The market for custom antibody market is segmented into service, type, source, research area, and end user. Based on service, the custom antibody market is segmented into antibody development, antibody production and purification, antibody fragmentation and labelling. In 2020, the antibody development segment held the largest share of the market, also the same segment is estimated to grow at a significant CAGR due to growing focus of researchers on high-quality custom antibodies for reproducibility during the forecast period.

Thermo Fisher Scientific Inc., Bio-Rad Laboratories Inc., Merck KGAA, Abcam, Genscript, Agilent Technologies, Inc., and Cell Signaling Technology, Inc. are among the leading companies in the Europe custom antibody market. The companies are focused on adopting organic growth strategies such as product launches and expansions to sustain their position in the dynamic market. For instance, in May 2020, Thermo Fisher Scientific has entered into collaboration with WuXi Diagnostics and the Mayo Clinic to develop ELISA test for detection of IgM and IgG antibodies to the novel coronavirus.

The report segments the Europe Custom Antibody market as follows:

By Service

• Antibody Development
• Antibody Production and Purification
• Antibody Fragmentation and Labelling

By Type

• Monoclonal Antibodies
• Polyclonal Antibodies
• Other Custom Antibodies

By Source

• Mice
• Rabbits
• Others

By Research Area

• Oncology
• Immunology
• Stem Cells
• Infectious Diseases
• Neurobiology
• Cardiovascular Diseases
• Others

By End User

• Pharmaceutical and Biotechnology Companies
• Academic and Research Institutes
• Contract Research Organizations

By Country

• Europe
  • Germany
  • UK
  • France
  • Spain
  • Italy
  • Rest of Europe